2-(2-ETHYL-IMIDAZOL-1-YL)-6-METHOXY-PYRIDIN-3-YLAMINE, 95.0%, 500mg

2-Bromo-4-methylpyridin-3-ol, 95.0%, 100mg

5-Amino-1-(2-bromophenyl)-1H-pyrazole-4-carbonitrile, 95.0%, 1g

4-Fluoro-3-nitrophenylacetic acid, 95.0%, 5g

7-AMINO-3,4-DIHYDRO-1,4-BENZOXAZEPIN-5(2H)-ONE, 95.0%, 500mg

4-Aminopyridine-2,6-dicarboxylic acid, 95.0%, 250mg

1,2-BENZISOTHIAZOLE, 6-BROMO-2,3-DIHYDRO-, 1,1-DIOXIDE, 95.0%, 1g

(3R)-1-(azetidin-3-yl)-3-fluoropyrrolidine dihydrochloride, 97.0%, 100mg

5-Bromo-1H-pyrazolo[3,4-b]pyridin-3-amine, 97%, 25g

2-Amino-4-fluorobenzaldehyde, 95.0%, 250mg

3-(5-BROMO-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE, 98%, 100g

Phase contrast slide set with 10x and S40x PLPHi IOS infinity corrected objectives and phase contrast rings for 10x/S40x

Diethyl 3-oxopentanedioate, 95.0%, 100g